throbber
NAPHCON A - naphazoline hydrochloride and pheniramine maleate solution/ drops
`Alcon Laboratories, Inc.
`
`Drug Facts
`
`----------
`
`Drug Facts
`
`Active ingredients
`Naphazoline hydrochloride
`0.025%
`Pheniramine maleate 0.3%
`
`Uses
`
`Purpose
`
`Redness reliever
`
`Antihistamine
`
`for the temporary relief of redness and itching of the eye(s) due to:
`
`ragweed
`pollen
`grass
`animal dander and hair
`
`Warnings
`
`For external use only
`
`Do not use
`
`if you are sensitive to any ingredient in this product
`if this solution changes color or becomes cloudy
`
`Ask a doctor before use if you have
`
`narrow angle glaucoma
`heart disease
`high blood pressure
`trouble urinating
`
`When using this product
`
`pupils may become enlarged temporarily causing light sensitivity
`overuse may cause more eye redness
`remove contact lenses before using
`to avoid contamination, do not touch tip of container to any surface
`replace cap after each use
`
`Stop use and ask a doctor if
`
`you feel eye pain
`changes in vision occur
`redness or irritation of the eye(s) gets worse or lasts more than 72 hours
`
`Keep out of the reach of children.
`
`If swallowed, get medical help or contact a Poison Control Center right away. Accidental swallowing by infants and children may lead to coma and
`marked reduction in body temperature.
`
`1/11
`
`Eye Therapies Exhibit 2192, 1 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Directions
`
`Drug Facts
`
`adults and children 6 years and over: put 1 or 2 drops in the affected eye(s) up to 4 times daily
`children under 6 years: ask a doctor
`
`Other information
`
`store at 20°-25°C (68°-77°F)
`protect from light
`
`Inactive ingredients
`
`benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate, sodium chloride, sodium hydroxide and/or hydrochloric acid
`
`Questions?
`
`In the U.S. call 1-800-757-9195 or visit www.alcon.com
`
`PRINCIPAL DISPLAY PANEL
`
`NAPHCON A®
`EYE DROPS
`
`Naphazoline HCl 0.025% and Pheniramine Maleate 0.3%
`
`Redness Reliever and Antihistamine Eye Drops
`
`Relieves Itching & Redness
`
`EYE ALLERGY RELIEF
`
`CLINICALLY PROVEN
`
`STERILE 15 mL (0.5 FL OZ)
`
`TAMPER EVIDENT: For your protection, this bottle has a seal imprinted with the word “Alcon” around the neck. Do not use if seal is damaged or
`missing at time of purchase.
`
`Actual Size
`
`Combines a redness reliever and an antihistamine for the temporary relief of itchy, red eyes.
`
`ALCON LABORATORIES, INC.
`6201 South Freeway
`Fort Worth, TX 76134
`
`©2002, 2008, 2014, 2015 Novartis
`
`9011949-0615
`
`Alcon®
`a Novartis company
`
`LOT:
`EXP.:
`
`2/11
`
`Eye Therapies Exhibit 2192, 2 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Drug Facts
`
`CLINICALLY PROVEN
`
`EYE ALLERGY RELIEF
`
`NAPHCON A®
`
`Naphazoline Hydrochloride 0.025% and Pheniramine Maleate 0.3%
`
`Ophthalmic Solution
`
`Redness Reliever and Antihistamine
`
`RELIEVES ITCHING & REDNESS
`
`EYE DROPS
`
`STERILE 15 mL (0.5 FL OZ)
`
`TAMPER EVIDENT: For your protection, this bottle has a seal imprinted with the word “Alcon” around the neck. Do not use if seal is damaged or
`missing at time of purchase.
`
`Actual Size
`
`3/11
`
`Eye Therapies Exhibit 2192, 3 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Drug Facts
`
`Combines a redness reliever and an antihistamine for the temporary relief of itchy, red eyes.
`
`ALCON LABORATORIES, INC.
`6201 South Freeway
`Fort Worth, TX 76134 USA
`
`Alcon
`
`LOT:
`EXP.:
`
`9017142-0419
`
`EYE ALLERGY RELIEF
`
`NAPHCON A®
`
`Naphazoline Hydrochloride 0.025% and Pheniramine Maleate 0.3%
`
`Ophthalmic Solution
`
`Redness Reliever and Antihistamine
`
`RELIEVES ITCHING & REDNESS
`
`4/11
`
`Eye Therapies Exhibit 2192, 4 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

` EYE DROPS
`
`CLINICALLY PROVEN
`
`STERILE 15 mL (0.5 FL OZ)
`
`Alcon®
`
`Drug Facts
`
`Active ingredients: Naphazoline EYE ALLERGY RELIEF Hydrochloride 0.025%, Pheniramine Maleate 0.3%.
`
`Uses: For the temporary relief of redness and itching of the eye(s) due to ragweed, pollen, grass, animal dander and hair.
`
`DIRECTIONS: Put 1 or 2 drops in the affected eye(s) up to 4 times daily. Children under 6 years: ask a doctor.
`
`WARNINGS: See Drug Facts on outer carton for Warnings. Remove contact lenses before using. To avoid contamination, do not touch tip of
`container to any surface.
`
`To open: push cap down while turning. Replace cap after each use.
`
`Keep this and all drugs out of reach of children.
`
`TAMPER EVIDENT: For your protection, this bottle has a seal imprinted with the word “Alcon” around the neck. Do not use if seal is damaged or
`missing at time of purchase.
`
`Store at 20° - 25°C (68° - 77°F).
`Protect from light.
`
`ALCON LABORATORIES, INC.
`FORT WORTH, TX 76134 USA
`
`LOT/EXP.:
`
`H15558-0419
`
`EYE ALLERGY RELIEF
`
`NAPHCON A®
`
`Naphazoline Hydrochloride 0.025%
`and Pheniramine Maleate 0.3%
`
`Ophthalmic Solution
`
`Redness Reliever and Antihistamine
`
`RELIEVES ITCHING & REDNESS
`
`EYE DROPS
`
`5/11
`
`Eye Therapies Exhibit 2192, 5 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Drug Facts
`
`CLINICALLY PROVEN
`
`STERILE 15 mL (0.5 FL OZ)
`
`Alcon®
`
`Active ingredients: Naphazoline
`Hydrochloride 0.025%,
`Pheniramine Maleate 0.3%.
`
`Uses: For the temporary relief of
`redness and itching of the eye(s)
`due to ragweed, pollen, grass,
`animal dander and hair.
`
`DIRECTIONS: Put 1 or 2 drops in
`the affected eye(s) up to 4 times
`daily. Children under 6 years:
`ask a doctor.
`
`WARNINGS: See Drug Facts on
`outer carton for Warnings. Remove
`contact lenses before using. To
`avoid contamination, do not touch
`tip of container to any surface.
`
`To open: push cap down while
`turning. Replace cap after each use.
`
`Keep this and all drugs out of reach
`of children.
`
`TAMPER EVIDENT: For your
`protection, this bottle has a seal
`imprinted with the word “Alcon”
`around the neck. Do not use if seal
`is damaged or missing at time of
`purchase. Store at 20° - 25°C
`(68° - 77°F). Protect from light.
`
`ALCON LABORATORIES, INC.
`FORT WORTH, TX 76134 USA
`
`LOT:
`
` EXP:
`
`300035727-0320
`
`6/11
`
`Eye Therapies Exhibit 2192, 6 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`PRINCIPAL DISPLAY PANEL
`
`Drug Facts
`
`Convenient • Take Anywhere
`
`EYE ALLERGY RELIEF
`
`POCKET SIZE
`
`NAPHCON A®
`
`Naphazoline Hydrochloride 0.025% and Pheniramine Maleate 0.3%
`
`Ophthalmic Solution
`
`Redness Reliever and Antihistamine
`
`Relieves Itching & Redness
`
`EYE DROPS
`
`CLINICALLY PROVEN
`
`STERILE Two 5 mL (0.17 FL OZ) Bottles
`
`TAMPER EVIDENT: For your protection, this bottle has a seal imprinted with the word “Alcon” around the neck. Do not use if seal is damaged or
`missing at time of purchase.
`
`ACTUAL SIZE
`
`Combines a redness reliever and an antihistamine for the temporary relief of itchy, red eyes.
`
`ACTUAL FILL
`
`ALCON LABORATORIES, INC.
`6201 South Freeway
`Fort Worth, TX 76134
`
`ALCON
`LOT:
`EXP.:
`
`9017143-0419
`
`7/11
`
`Eye Therapies Exhibit 2192, 7 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Drug Facts
`
`EYE ALLERGY RELIEF
`
`NAPHCON A®
`
`Naphazoline Hydrochloride 0.025% and Pheniramine Maleate 0.3%
`
`Ophthalmic Solution
`
`Redness Reliever and Antihistamine
`
`RELIEVES ITCHING & REDNESS
`
`EYE DROPS
`
`CLINICALLY PROVEN
`
`STERILE 5mL (0.17 FL OZ )
`
`Active ingredients: Naphazoline Hydrochloride 0.025%, Pheniramine Maleate 0.3%.
`
`Uses: For the temporary relief of redness and itching of the eye(s) due to ragweed, pollen, grass, animal dander and hair.
`
`DIRECTIONS: Put 1 or 2 drops in the affected eye(s) up to 4 times daily. Children under 6 years: ask a doctor.
`
`WARNINGS: See Drug Facts on outer carton for Warnings. Remove contact lenses before using. To avoid contamination, do not touch tip of
`container to any surface. To open: push cap down while turning. Replace cap after each use. Keep this and all drugs out of reach of children.
`
`TAMPER EVIDENT: For your protection, this bottle has a seal imprinted with the word “Alcon” around the neck. Do not use if seal is damaged or
`missing at time of purchase.
`
`8/11
`
`Eye Therapies Exhibit 2192, 8 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Drug Facts
`
`Store at 20° - 25°C (68° - 77°F).
`
`Protect from light.
`
`ALCON LABORATORIES, INC.
`FORT WORTH, TX 76134 USA
`
`LOT
`EXP:
`
`H15557-0419
`
`PRINCIPAL DISPLAY PANEL
`
`CONVENIENT • TAKE ANYWHERE
`
`EYE ALLERGY RELIEF
`
`POCKET SIZE
`
`NAPHCON A®
`
`Naphazoline Hydrochloride 0.025% and Pheniramine Maleate 0.3%
`
`Ophthalmic Solution
`
`Redness Reliever and Antihistamine
`
`RELIEVES ITCHING & REDNESS
`
`EYE DROPS
`
`CLINICALLY PROVEN
`
`STERILE 5 mL (0.17 FL OZ)
`
`TAMPER EVIDENT: For your protection, this bottle has a seal imprinted with the word “Alcon” around the neck. Do not use if seal is damaged or
`missing at time of purchase.
`
`ACTUAL SIZE
`
`Combines a redness reliever and an antihistamine for temporary relief of itchy, red eyes.
`
`ACTUAL FILL
`
`ALCON LABORATORIES, INC.
`6201 South Freeway
`Fort Worth, TX 76134
`
`Alcon
`
`LOT:
`
`9/11
`
`Eye Therapies Exhibit 2192, 9 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`EXP.:
`
`9017128-0419
`
`Drug Facts
`
`NAPHCON A
`naphazoline hydrochloride and pheniramine maleate solution/ drops
`Product Information
`Product Type
`Route of Administration
`Active Ingredient/Active Moiety
`
`HUMAN OTC DRUG
`OPHTHALMIC
`
`Item Code (Source)
`
`NDC:0065-0085
`
`Ingredient Name
`Naphazoline Hydrochloride (UNII: MZ1131787D) (Naphazoline - UNII:H231GF11BV)
`Pheniramine Maleate (UNII: NYW905655B) (Pheniramine - UNII:134FM9ZZ6M)
`Inactive Ingredients
`
`Basis of Strength
`Naphazoline Hydrochloride
`Pheniramine Maleate
`
`Strength
`0.25 mg in 1 mL
`3 mg in 1 mL
`
`Ingredient Name
`
`Strength
`
`Benzalkonium Chloride (UNII: F5UM2KM3W7)
`Boric Acid (UNII: R57ZHV85D4)
`Edetate Disodium (UNII: 7FLD91C86K)
`Water (UNII: 059QF0KO0R)
`
`10/11
`
`Eye Therapies Exhibit 2192, 10 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

`

`Drug Facts
`
`Sodium Borate (UNII: 91MBZ8H3QO)
`Sodium Chloride (UNII: 451W47IQ8X)
`Sodium Hydroxide (UNII: 55X04QC32I)
`Hydrochloric Acid (UNII: QTT17582CB)
`
`Packaging
`#
`Item Code
`1 NDC:0065-0085-15
`1
`2 NDC:0065-0085-38
`2
`3 NDC:0065-0085-42
`3
`4 NDC:0065-0085-52
`4
`
`Package Description
`
`1 in 1 CARTON
`15 mL in 1 BOTTLE; Type 0: Not a Combination Product
`1 in 1 CARTON
`30 mL in 1 BOTTLE; Type 0: Not a Combination Product
`2 in 1 CARTON
`5 mL in 1 BOTTLE; Type 0: Not a Combination Product
`1 in 1 CARTON
`5 mL in 1 BOTTLE; Type 0: Not a Combination Product
`
`Marketing Information
`Application Number or Monograph Citation
`Marketing Category
`NDA020226
`NDA
`Labeler - Alcon Laboratories, Inc. (008018525)
`Registrant - Alcon Laboratories, Inc. (008018525)
`Establishment
`
`Marketing Start Date Marketing End Date
`06/08/1994
`
`06/08/1994
`
`06/08/1994
`
`06/08/1994
`
`02/28/2019
`
`11/01/2023
`
`11/30/2021
`
`Marketing Start Date
`06/08/1994
`
`Marketing End Date
`
`Name
`Alcon Research LLC
`
`Address
`
`ID/FEI
`007672236
`
`Business Operations
`manufacture(0065-0085)
`
`Revised: 6/2022
`Document Id: fe43207e-46ec-4284-b54f-c279edba278b
`Set id: 4d8412ff-0e59-4a6a-9f3e-4e6f6204bf58
`Version: 13
`Effective Time: 20220622
`
`Alcon Laboratories, Inc.
`
`11/11
`
`Eye Therapies Exhibit 2192, 11 of 11
`Slayback v. Eye Therapies - IPR2022-00142
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket